Cabaletta Bio, Inc.
CABA
Price:
$4.015
Market Cap:
$196.13M
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage...[Read more]
Industry
Biotechnology
IPO Date
2019-10-25
Stock Exchange
NASDAQ
Ticker
CABA
The ROE as of September 2024 (TTM) for Cabaletta Bio, Inc. (CABA) is -43.98%
According to Cabaletta Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.98%. This represents a change of 298.08% compared to the average of -11.05% of the last 4 quarters.
Cabaletta Bio, Inc. (CABA) Historical ROE (quarterly & annually)
How has CABA ROE performed in the past?
The mean historical ROE of Cabaletta Bio, Inc. over the last ten years is 8.16%. The current -43.98% ROE has changed -638.75% with respect to the historical average. Over the past ten years (40 quarters), CABA's ROE was at its highest in in the March 2018 quarter at 205.02%. The ROE was at its lowest in in the March 2023 quarter at -16.10%.
Average
8.16%
Median
-28.65%
Minimum
-49.57%
Maximum
114.14%
Cabaletta Bio, Inc. (CABA) ROE by Quarter and Year
Discovering the peaks and valleys of Cabaletta Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.72%
Maximum Annual ROE = 114.14%
Minimum Annual Increase = -109.56%
Minimum Annual ROE = -49.57%
| Year | ROE | Change |
|---|---|---|
| 2023 | -28.65% | -42.20% |
| 2022 | -49.57% | 28.42% |
| 2021 | -38.60% | 30.14% |
| 2020 | -29.66% | 171.72% |
| 2019 | -10.92% | -109.56% |
| 2018 | 114.14% | 13.69% |
Cabaletta Bio, Inc. (CABA) Average ROE
How has CABA ROE performed in the past?
The current ROE of Cabaletta Bio, Inc. (CABA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-38.94%
5-year avg
-31.48%
10-year avg
8.16%
Cabaletta Bio, Inc. (CABA) ROE vs. Peers
How is CABA’s ROE compared to its peers?
Cabaletta Bio, Inc.’s ROE is less than TCR2 Therapeutics Inc. (0%), greater than Revolution Medicines, Inc. (-89.51%), greater than Black Diamond Therapeutics, Inc. (-34.57%), greater than Atreca, Inc. (-69.08%), greater than Passage Bio, Inc. (-195.22%), greater than 89bio, Inc. (-70.73%), greater than Madrigal Pharmaceuticals, Inc. (-35.42%), greater than Pliant Therapeutics, Inc. (-95.61%), greater than Arcellx, Inc. (-41.05%), greater than Stoke Therapeutics, Inc. (-12.42%), greater than Harpoon Therapeutics, Inc. (-57.89%), greater than Alector, Inc. (-904.27%), greater than Larimar Therapeutics, Inc. (-102.63%), greater than Homology Medicines, Inc. (-37.84%), greater than Day One Biopharmaceuticals, Inc. (-100.91%), greater than null (-122.70%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $58.11M | |
| -89.51% | $7.38B | |
| -34.57% | $312.47M | |
| -69.08% | $3.57M | |
| -195.22% | $46.26M | |
| -70.73% | $882.23M | |
| -35.42% | $5.06B | |
| -95.61% | $719.89M | |
| -41.05% | $4.14B | |
| -12.42% | $772.34M | |
| -57.89% | $865.08M | |
| -904.27% | $566.41M | |
| -102.63% | $430.69M | |
| -37.84% | $3.02M | |
| -100.91% | $1.21B | |
| -122.70% | $0 |
Build a custom stock screener for Cabaletta Bio, Inc. (CABA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabaletta Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cabaletta Bio, Inc. (CABA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cabaletta Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cabaletta Bio, Inc.'s ROE?
How is the ROE calculated for Cabaletta Bio, Inc. (CABA)?
What is the highest ROE for Cabaletta Bio, Inc. (CABA)?
What is the 3-year average ROE for Cabaletta Bio, Inc. (CABA)?
What is the 5-year average ROE for Cabaletta Bio, Inc. (CABA)?
How does the current ROE for Cabaletta Bio, Inc. (CABA) compare to its historical average?